Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function*

To explore the basis of metastasis, we compared the human breast cancer lines MCF-7 and MDA-MB453, which have low invasive ability, with their sublines MCF7-I4 and MDA-MB453-I4 with high invasive ability for gene expression and signaling pathways. We previously showed that the I4 lines had dramatically elevated levels of Twist compared with their parental lines. In this study, we observed significantly increased STAT3 Tyr705 phosphorylation, but not the STAT3 protein levels, in the I4 lines. Activation of STAT3 by interleukin-6 or expression of activated Src induced Twist expression at protein and mRNA levels. Inhibiting STAT3 by a small molecule inhibitor, JSI-124, STAT3 small hairpin RNAs, or dominant negative STAT3 resulted in significant reduction of Twist protein and mRNA expression. STAT3 directly bound to the second proximal STAT3-binding site on the human Twist promoter and activated its transcriptional activity. Inhibition of STAT3 reduced migration, invasion, and colony formation of the I4 cells. Ectopic expression of Twist significantly rescued those phenotypes. Ten normal and 46 tumor specimens of breast tissues were examined for activation of STAT3 and expression of Twist. There was a strong correlation between Tyr705 p-STAT3 and Twist level in the late stage tumor tissues. Our results indicate that activated STAT3 transcriptionally induces Twist, which plays an important role in promoting migration, invasion, and anchorage-independent growth. Together with our previous observation that Twist transcriptionally induces AKT2 to mediate Twist-promoted oncogenic functions, we conclude that STAT3, Twist, and AKT2 form a functional signaling axis to regulate pivotal oncogenic properties of cancer cells.

[1]  Sheng-Chieh Hsu,et al.  Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. , 2007, Cancer research.

[2]  Hiroshi Yamaguchi,et al.  Twist, a novel oncogene, is upregulated in pancreatic cancer: Clinical implication of Twist expression in pancreatic juice , 2007, International journal of cancer.

[3]  C. Pham,et al.  Upregulation of Twist-1 by NF-κB Blocks Cytotoxicity Induced by Chemotherapeutic Drugs , 2007, Molecular and Cellular Biology.

[4]  D. Xie,et al.  Significance of TWIST expression and its association with E-cadherin in bladder cancer. , 2007, Human pathology.

[5]  G. Z. Cheng,et al.  Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. , 2007, Cancer research.

[6]  Sheung Tat Fan,et al.  Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition , 2006, Clinical Cancer Research.

[7]  S. Law,et al.  Upregulation of Twist in oesophageal squamous cell carcinoma is associated with neoplastic transformation and distant metastasis , 2006, Journal of Clinical Pathology.

[8]  C. Glackin,et al.  N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. , 2006, Cancer research.

[9]  K. Imai,et al.  Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells , 2006, Oncogene.

[10]  P. V. van Diest,et al.  Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. , 2005, Cancer research.

[11]  A. Puisieux,et al.  A twist for survival and cancer progression , 2005, British Journal of Cancer.

[12]  C. Fielding,et al.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Eric B Haura,et al.  Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer , 2005, Nature Clinical Practice Oncology.

[14]  R. Arlinghaus,et al.  Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. , 2005, Cancer research.

[15]  R. Gaynor,et al.  Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation. , 2005, Molecular cell.

[16]  S. John,et al.  Signal transducer and activator of transcription (STAT) signalling and T‐cell lymphomas , 2005, Immunology.

[17]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[18]  T. Hirano,et al.  Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer , 2004, Nature.

[19]  F. Ali-Osman,et al.  Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis , 2004, Oncogene.

[20]  M. Justice,et al.  A twist code determines the onset of osteoblast differentiation. , 2004, Developmental cell.

[21]  Nicola Gebbia,et al.  STAT proteins: From normal control of cellular events to tumorigenesis , 2003, Journal of cellular physiology.

[22]  G. Stein,et al.  Regulation of the Bone-Specific Osteocalcin Gene by p300 Requires Runx2/Cbfa1 and the Vitamin D3 Receptor but Not p300 Intrinsic Histone Acetyltransferase Activity , 2003, Molecular and Cellular Biology.

[23]  J. Turkson,et al.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. , 2003, Cancer research.

[24]  Jingwen Liu,et al.  Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells , 2003, Oncogene.

[25]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[26]  K. Yoshikawa,et al.  STAT3 Deficiency in Keratinocytes Leads to Compromised Cell Migration through Hyperphosphorylation of p130 cas * , 2002, The Journal of Biological Chemistry.

[27]  R. Jove,et al.  Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  A. Schier,et al.  Stat3 Controls Cell Movements during Zebrafish Gastrulation. , 2002, Developmental cell.

[29]  W. Hiddemann,et al.  Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. , 2002, Experimental hematology.

[30]  M. Baylies,et al.  Dimerization partners determine the activity of the Twist bHLH protein during Drosophila mesoderm development. , 2001, Development.

[31]  A. Munnich,et al.  Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. , 2000, Human molecular genetics.

[32]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[33]  A. Hamburger,et al.  ErbB‐2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells , 1999, International journal of cancer.

[34]  L. Kedes,et al.  Twist is a potential oncogene that inhibits apoptosis. , 1999, Genes & development.

[35]  C. S. Zong,et al.  Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth* , 1998, The Journal of Biological Chemistry.

[36]  J. Darnell,et al.  Stat3 Activation Is Required for Cellular Transformation by v-src , 1998, Molecular and Cellular Biology.

[37]  R. Jove,et al.  Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  R. Pignolo,et al.  Cloning of the human twist gene: its expression is retained in adult mesodermally-derived tissues. , 1997, Gene.

[39]  M. Bate,et al.  twist: A Myogenic Switch in Drosophila , 1996, Science.

[40]  Y. Tan,et al.  Activation and association of Stat3 with Src in v-Src-transformed cell lines , 1996, Molecular and cellular biology.

[41]  R. Jove,et al.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.

[42]  J. Darnell,et al.  A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. , 1995, Genes & development.

[43]  P. Heinrich,et al.  Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level , 1993, Molecular and cellular biology.